Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)
- PMID: 35739328
- PMCID: PMC9225876
- DOI: 10.1007/s00520-022-07103-5
Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)
Figures

Similar articles
-
Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection.Curr Opin Hematol. 1997 May;4(3):200-6. doi: 10.1097/00062752-199704030-00008. Curr Opin Hematol. 1997. PMID: 9209837 Review.
-
[Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].Di Yi Jun Yi Da Xue Xue Bao. 2004 Sep;24(9):1051-2. Di Yi Jun Yi Da Xue Xue Bao. 2004. PMID: 15447861 Chinese.
-
Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.J Infect Dis. 2002 May 15;185(10):1490-501. doi: 10.1086/340221. Epub 2002 Apr 19. J Infect Dis. 2002. PMID: 11992286 Review.
-
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.Crit Care. 2011;15(1):R58. doi: 10.1186/cc10031. Epub 2011 Feb 10. Crit Care. 2011. PMID: 21310070 Free PMC article. Review.
-
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.J Infect Dis. 1999 Mar;179 Suppl 2:S342-52. doi: 10.1086/513857. J Infect Dis. 1999. PMID: 10081506 Review.
Cited by
-
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma.Biomedicines. 2024 Apr 11;12(4):848. doi: 10.3390/biomedicines12040848. Biomedicines. 2024. PMID: 38672201 Free PMC article. Review.
-
Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial.Support Care Cancer. 2023 Dec 16;32(1):34. doi: 10.1007/s00520-023-08176-6. Support Care Cancer. 2023. PMID: 38103088 Free PMC article. Clinical Trial.
-
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation.Bone Marrow Transplant. 2024 Oct;59(10):1466-1476. doi: 10.1038/s41409-024-02388-y. Epub 2024 Aug 8. Bone Marrow Transplant. 2024. PMID: 39117736
-
Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study.Viruses. 2024 Sep 14;16(9):1462. doi: 10.3390/v16091462. Viruses. 2024. PMID: 39339938 Free PMC article.
-
Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases.Pharmaceutics. 2024 Apr 13;16(4):535. doi: 10.3390/pharmaceutics16040535. Pharmaceutics. 2024. PMID: 38675196 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources